Interventional News Issue 68 – November 2017



  • Big strides in evidence backing prostatic artery embolization
  • Randomised data reveal theoretical benefit with microwave ablation “does not translate into clinical benefit” for hepatocellular carcinoma patients
  • Women largely unaware of uterine fibroid embolisation
  • First patient treated with vandetanib-eluting beads that are visible on CT scans
  • Roberto Iezzi: Future directions for ablation in interventional oncology
  • Julian Soares and Alistair Craig: Changing landscape of IR training in the UK
  • Profile: Andrew Holden

This edition is intended for readers outside of the USA. For the US edition, please click here.


Please enter your comment!
Please enter your name here